Thomas Fuchs, Cimeio CEO
April 13, 2022 08:00 AM EDT
Financing
Startups
Cell/Gene Tx

'Tru­ly dif­fer­en­t': Roche's for­mer hema­tol­ogy leader shifts a new Ver­sant biotech in­to gear

Kyle LaHucik

Senior Reporter

While head­ing up the hema­tol­ogy unit at Roche/Genen­tech, Thomas Fuchs and his team “looked at every­thing” when try­ing to ad­dress the ar­eas of un­met need …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times